Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and management of chronic kidney disease (CKD) in adults and children.

Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) inhibitors as first-line therapy, and personalized treatment approaches for kidney and ...

Chronic Kidney Disease (CKD), as per Kidney Disease Improving Global Outcomes (KDIGO) is defined as estimated ... medicines causing kidney injury, inflammation of the kidney, urological causes ...

The Accuryn Monitor tracks urine output and detects AKI based on KDIGO guidelines, hours before standard of ... About Accuryn Medical Accuryn Medical, Inc. is committed to addressing Acute Kidney ...